All News

Pregnancy in SpA Patients: Dr Rachel Tate ( @uptoTate) #ACR20 https://t.co/GPrwd9HU5W https://t.co/TbwN4dZNul

Links:

https://bit.ly/3lug6zz

Dr. John Cush RheumNow ( View Tweet)

Dec 04, 2020

New Treatments in Axial Spondyloarthritis: Dr. Antoni Chan ( @synovialjoints) discuses two abstracts presented at the #ACR20 annual meeting. https://t.co/bh7l6C8p7P https://t.co/RN60iWCmet

Links:

https://bit.ly/39wSuIn

Dr. John Cush RheumNow ( View Tweet)

Dec 02, 2020

Dr. Conway ( @RichardPAConway) and Dr. Maguire discuss abstract #1323 presented at the #ACR20 on pregnancy in Spondyloarthritis. https://t.co/YyWOuiq3jn https://t.co/SnodUbKZTx

Links:

https://bit.ly/3lfbo9y

Dr. John Cush RheumNow ( View Tweet)

Nov 30, 2020

SpA: Etiology to Diagnosis to Treatment - An Abstract Roundup by Dr. Robert Chao ( @doctorRBC) #ACR20 https://t.co/wR0inoR8jp https://t.co/7SFkThkPSr

Links:

https://bit.ly/3eTWhQM

Dr. John Cush RheumNow ( View Tweet)

Nov 29, 2020

#BestACR20Tweets RT @doctorRBC : Gender disparity in Ankylosing Spondylitis symptoms. 1⃣Women ⬆️Achilles tendonitis, plantar fasciitis, joint swelling, BASDAI>40, DMARD use 2⃣HLA-B not associated w/ enthesitis @RheumNow #ACR20 Abs#1872 https://t.co/pBcpuqgq0K https://t.co/YWKFUdIgMl

Links:

https://bit.ly/39chcO7

Dr. John Cush RheumNow ( View Tweet)

Nov 27, 2020

SpA: Etiology to Diagnosis to Treatment - An Abstract Roundup

Save

d Robert Chao, MD

Nov 25, 2020

Here's a review of ten abstracts and presentations on spondyloarthritis encompassing a wide range of topics from etiology to diagnosis to treatment.

Read Article

#BestACR20Tweets RT @ejdein1 : #ACR20 Abs#L11. Efficacy of TOFA vs PBO in AS. At week 16, %ASAS20 responders 56% v 29% PBO; %ASAS40 40% vs 12%. @RheumNow #ACRBest https://t.co/knduk3l6xV https://t.co/SNommxn1jA

Links:

https://bit.ly/3l0nMJH

Dr. John Cush RheumNow ( View Tweet)

Nov 25, 2020

Nomenclature, Uveitis and Other Spondyloarthritis Features with Dr. Lianne Gensler #ACR20 https://t.co/zql7iySXOA https://t.co/PY9k108QTc

Links:

https://bit.ly/33eSIzU

Dr. John Cush RheumNow ( View Tweet)

Nov 25, 2020

#BestACR20Tweets RT @synovialjoints : Can we find Axial Spa (FaxSpa) using social media? This study used an online screening tool (A-tool) on social media in patients with back pain. 42% had a positive screen and referred for review @RheumNow #ACR20 Abstr#1894

Dr. John Cush RheumNow ( View Tweet)

Nov 25, 2020

#BestACR20Tweets RT @synovialjoints : The majority of patients with axSpA were able to use an axSpA smartphone app. recording BASDAI, BASFI 2 weekly. Current disease activity influence adherence to reporting @RheumNow #ACR20 Abstr#1890

Dr. John Cush RheumNow ( View Tweet)

Nov 24, 2020

#BestACR20Tweets RT @DrPetryna : #ACR20 abs1535 retrospective study of SI MRI reveals 20% pts w/out spondyloarthritis have BME on an MRI, predominantly in the antero-middle quadrant. Erosions were seen in 31% of healthy patients and in 61% of patients with spondyloarthritis

Dr. John Cush RheumNow ( View Tweet)

Nov 23, 2020

#BestACR20Tweets RT @Janetbirdope : Filgo decreased MRI inflammation of many structures early in Rx in SpA which seems novel says w Maksymowych 5M015 @RheumNow #ACR20 @CRASCRRheum #ACRbest https://t.co/5HQiIettjh https://t.co/NwFMkLIhWw

Links:

https://bit.ly/3lP3dB8

Dr. John Cush RheumNow ( View Tweet)

Nov 21, 2020

Check out of video by Dr. Rachel Tate ( @uptoTate ) titled "Treat to Target in Spondyloarthritis". #ACR20 https://t.co/7ThVtmguFI https://t.co/on9m0qtse3

Links:

https://bit.ly/2UuXcO1

Dr. John Cush RheumNow ( View Tweet)

Nov 20, 2020

#BestACR20Tweets RT @synovialjoints : New mode of action treatment in AS. The SELECT-AXIS 1 showed Upadacitinib 15mg od showed sustained efficacy over 1 year @RheumNow #ACR20 Abstr#2023 #ACRbest https://t.co/Auo3AMNTDw

Links:

https://bit.ly/3feCeMW

Dr. John Cush RheumNow ( View Tweet)

Nov 20, 2020

#BestACR20Tweets RT @KDAO2011 : FDA updates 6/16/20 canakinumab for AOSD 5/29/20 ixekizumab for nr-AxSpa 80 mg q4wks 3/9/20 nintedanib for progressive ILD 1/29/20 and 6/16/20 secukinumab nr-axSpa 150 mg q4wks, AS 300 mg SQ q4weeks 1/17/20 belimumab label for black pts removed

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

#BestACR20Tweets "RT @KDAO2011 : Meta-analysis of studies - 4104 pregnancies axSpa/PsA: higher risk for: preterm labor, small for gestational age, C-section No change in miscarriage/stillbirth, gest.diabetes #ACR20, @rheumnow Abstr#1771 https://t.co/xl1YyRPavX"

Links:

https://bit.ly/3f6WMa6

Dr. John Cush RheumNow ( View Tweet)

Nov 17, 2020

Read Dr. Robert Chao's (@doctorRBC) review of ten abstracts and presentations on spondyloarthritis encompassing a wide range of topics from etiology to diagnosis to treatment from #ACR20. https://t.co/BeG1DMssoU https://t.co/ywbvH7qmHY

Links:

https://bit.ly/3f1NVqd

Dr. John Cush RheumNow ( View Tweet)

Nov 16, 2020

Our latest article is asking: "Erosions on X-ray: can we delegate this to the computers?" by David Liew ( @drdavidliew) #ACR20 https://t.co/YvKjAWebT9 https://t.co/kIqeX3X0n8

Links: